DiseaseID 17495
巨噬细胞性肌筋膜炎
disease
SNOMEDCT_US_2016_09_01:A rare systemic inflammatory disease associated with long-lasting biopersistance of post-vaccinal aluminic granulomas. More than 600 cases have been reported to date, most of them in France. This i
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Disease: 1Symptom: 3Target: 15Links: 27
Arranging relationship network...
Record Fields
Scalar fields from the final disease record.
- Disease Id
- 17495
- Core Entity Id
- 75735
- Source Entity Count
- 1
- Preferred Name
- Macrophagic Myofasciitis
- Name Cn
- 巨噬细胞性肌筋膜炎
- Name Pinyin
- Ju Shi Xi Bao Xing Ji Jin Mo Yan
- Name En
- Macrophagic Myofasciitis
- Name Latin
- Bilingual Status
- complete
- Disease Type
- disease
- Umls Disease Type
- Disease or Syndrome
- Disgenet Type
- disease
- Mesh Class
- Nervous System Diseases; Musculoskeletal Diseases
- Do Class
- Hpo Class
- Mesh Class Name
- Musculoskeletal Diseases; Nervous System Diseases
- Hpo Class Name
- Do Class Name
- Disease Definition
- SNOMEDCT_US_2016_09_01:A rare systemic inflammatory disease associated with long-lasting biopersistance of post-vaccinal aluminic granulomas. More than 600 cases have been reported to date, most of them in France. This is probably due to large-scale vaccination with aluminum-containing vaccines in France during the 1990s. The disease generally manifests with myalgias of variable intensity, and is usually associated with weakness and chronic fatigue. Belongs to the group of Autoimmune/inflammatory Syndromes Induced by Adjuvants (ASIA): it is triggered, probably in genetically predisposed patients, by injection of vaccines containing aluminum hydroxide and may occur up to 10 years following vaccination.|SNOMEDCT_US_2016_09_01:A rare systemic inflammatory disease associated with long-lasting biopersistance of post-vaccinal aluminic granulomas. More than 600 cases have been reported to date, most of them in France. This is probably due to large-scale vaccination with aluminium-containing vaccines in France during the 1990s. The disease generally manifests with myalgias of variable intensity, and is usually associated with weakness and chronic fatigue. Belongs to the group of Autoimmune/inflammatory Syndromes Induced by Adjuvants (ASIA): it is triggered, probably in genetically predisposed patients, by injection of vaccines containing aluminium hydroxide and may occur up to 10 years following vaccination.
- Version
- v2
- Suppressed
- No
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
Macrophagic Myofasciitis
Role
preferred
Cross References
Trusted external identifiers retained for this final record.
Herb
HBDIS020322
Umls
C2931639
Sym Map
SMDE10630
Dis Ge Net
C2931639
Umls Sty
T047
Me Sh Class
C05C10
Etcm Disease
Macrophagic Myofasciitis
Tcmbank Disease
2068
Itcmdb Generated
ITX-DISEASE-ACD97DDFDDFD
Attributes
Merged source attributes and domain-specific metadata.
Version
v2
Suppress
0
Page Title
Disease Macrophagic Myofasciitis Details page
Disease Type
disease
Umls Disease Type
Disease or Syndrome
Basic Information
Disease Name
Macrophagic Myofasciitis
Global Category
Rare diseases
Anatomical Category
Neuronal diseases
Disease Definition
SNOMEDCT_US_2016_09_01:A rare systemic inflammatory disease associated with long-lasting biopersistance of post-vaccinal aluminic granulomas. More than 600 cases have been reported to date, most of them in France. This is probably due to large-scale vaccination with aluminum-containing vaccines in France during the 1990s. The disease generally manifests with myalgias of variable intensity, and is usually associated with weakness and chronic fatigue. Belongs to the group of Autoimmune/inflammatory Syndromes Induced by Adjuvants (ASIA): it is triggered, probably in genetically predisposed patients, by injection of vaccines containing aluminum hydroxide and may occur up to 10 years following vaccination.|SNOMEDCT_US_2016_09_01:A rare systemic inflammatory disease associated with long-lasting biopersistance of post-vaccinal aluminic granulomas. More than 600 cases have been reported to date, most of them in France. This is probably due to large-scale vaccination with aluminium-containing vaccines in France during the 1990s. The disease generally manifests with myalgias of variable intensity, and is usually associated with weakness and chronic fatigue. Belongs to the group of Autoimmune/inflammatory Syndromes Induced by Adjuvants (ASIA): it is triggered, probably in genetically predisposed patients, by injection of vaccines containing aluminium hydroxide and may occur up to 10 years following vaccination.
Me Sh Disease Class
Nervous System Diseases; Musculoskeletal Diseases
Dis Ge Net Disease Type
disease
Disease Class Name Me Sh
Musculoskeletal Diseases; Nervous System Diseases
Umls Semantic Type Name
Disease or Syndrome